Kenyon J L, Sutko J L
J Gen Physiol. 1987 Jun;89(6):921-58. doi: 10.1085/jgp.89.6.921.
We have used the two-microelectrode voltage-clamp technique to investigate the components of membrane current that contribute to the formation of the early part of the plateau phase of the action potential of calf cardiac Purkinje fibers. 3,4-Diaminopyridine (50 microM) reduced the net transient outward current elicited by depolarizations to potentials positive to -30 mV but had no consistent effect on contraction. We attribute this effect to the blockade of a voltage-activated transient potassium current component. Ryanodine (1 microM), an inhibitor of sarcoplasmic reticulum calcium release and intracellular calcium oscillations in Purkinje fibers (Sutko, J.L., and J.L. Kenyon. 1983. Journal of General Physiology. 82:385-404), had complex effects on membrane currents as it abolished phasic contractions. At early times during a depolarization (5-30 ms), ryanodine reduced the net outward current. We attribute this effect to the loss of a component of calcium-activated potassium current caused by the inhibition of sarcoplasmic reticulum calcium release and the intracellular calcium transient. At later times during a depolarization (50-200 ms), ryanodine increased the net outward current. This effect was not seen in low-sodium solutions and we could not observe a reversal potential over a voltage range of -100 to +75 mV. These data suggest that the effect of ryanodine on the late membrane current is attributable to the loss of sodium-calcium exchange current caused by the inhibition of sarcoplasmic reticulum calcium release and the intracellular calcium transient. Neither effect of ryanodine was dependent on chloride ions, which suggests that chloride ions do not carry the ryanodine-sensitive current components. Strontium (2.7 mM replacing calcium) and caffeine (10 mM), two other treatments that interfere with sarcoplasmic reticulum function, had effects in common with ryanodine. This supports the hypothesis that the effects of ryanodine may be attributed to the inhibition of sarcoplasmic reticulum calcium release.
我们运用双微电极电压钳技术,研究了参与小牛心脏浦肯野纤维动作电位平台期早期形成的膜电流成分。3,4 - 二氨基吡啶(50微摩尔)可降低去极化至高于 - 30毫伏电位时引发的净瞬时外向电流,但对收缩无一致影响。我们将此效应归因于对电压激活的瞬时钾电流成分的阻断。Ryanodine(1微摩尔)是浦肯野纤维肌浆网钙释放和细胞内钙振荡的抑制剂(Sutko, J.L., 和J.L. Kenyon. 1983. 《普通生理学杂志》. 82:385 - 404),对膜电流有复杂影响,因为它消除了阶段性收缩。在去极化早期(5 - 30毫秒),Ryanodine降低了净外向电流。我们将此效应归因于肌浆网钙释放和细胞内钙瞬变受抑制导致的钙激活钾电流成分丧失。在去极化后期(50 - 200毫秒),Ryanodine增加了净外向电流。在低钠溶液中未观察到这种效应,并且在 - 100至 + 75毫伏的电压范围内我们未观察到反转电位。这些数据表明,Ryanodine对晚期膜电流的影响归因于肌浆网钙释放和细胞内钙瞬变受抑制导致的钠钙交换电流丧失。Ryanodine的两种效应均不依赖于氯离子,这表明氯离子不携带Ryanodine敏感的电流成分。锶(2.7毫摩尔替代钙)和咖啡因(10毫摩尔)是另外两种干扰肌浆网功能的处理方法,它们与Ryanodine有共同效应。这支持了Ryanodine的效应可能归因于肌浆网钙释放受抑制这一假说。